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The paper gives an overview of the general regulatory framework relevant for the 
food industry in the EU and USA, as well as some information on the character of 
innovations in the food chain. In a second step three very innovative fields in the 
food industry are analysed whether the existing regulatory framework has hindering 
or facilitating impacts on innovations: the use of genetic engineering, health-
oriented Functional Foods and organic food products. Empirical results among a 
survey of EU food manufacturing firms are presented which assess the current 
framework in the EU and its impact on innovation activities. The paper concludes 
with some remarks about the role of regulations for R&D and marketing of new 
products in the food industry. 
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The impact of regulation on the development of new prod-
ucts in the food industry 
 
The question of regulation, innovation and their impact on competitiveness in 
global markets has a high relevance for the food industry. However, little has been 
done to understand the effect of regulation on the capacity of such a traditional in-
dustry like the food industry to innovate and to introduce new products and services 
in the market. The debate has taken place at a level of anecdotal evidence and poor 
systematic empirical foundations. In addition, most of the approaches assume a 
static framework, not recognising the long-term dynamic feedback loops between 
regulation and technical progress and new markets. Finally, the majority of the ex-
pressed statements, especially from industry, come to the conclusion that the nega-
tive impacts of regulation outweigh the positive effects. This paper aims to bridge 
the gap between the challenge to shape a regulatory framework, which allows the 
emergence of new markets, and even to use regulation as an instrument to foster 





For this purpose a methodological set was used, consisting of reviewing existing 
literature and reports, marketing statistics, press releases and other documents of 
companies and trade associations as well as regulatory and legal documents. In ad-
dition, a questionnaire-based survey among manufacturing companies and research 
institutions of the EU was carried out in order to analyse the view of different in-
dustries – among others the food processing industry – concerning the regulatory 
framework in the EU and its interrelationships to innovation activities in different 
fields. The target group of the survey were besides the food processing industry the 
environmental sector, pharmaceutical industry, mechanical engineering, electro-
technology, and transport and telecommunication services. Finally expert interviews 
were used to complement the picture and give additional background insight in the 
analysed processes.  
 
Regulatory regime of the food industry 
 
Due to the increasing internationalisation of food and commodity markets, political 
and regulatory influential factors gain increasing relevance for the food industry. By 
speeding up the integration of international markets and increasing numbers of in-
ternational joint ventures, the food industry is more and more influenced by interna-
tional legislation. Against this background single national states are no longer able 
to perform an independent food legislation for their own country.  
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A specific relevance for food production and food processing have the standards of 
the so-called Codex Alimentarius. The Codex Alimentarius encloses all standards, 
voluntary agreements and recommendations of the so-called Codex Alimentarius 
Commission. This Codex Commission is the highest international committee for 
defining worldwide accepted standards for foods. It is a common committee of the 
Food and Agriculture Organisation of the United Nations (FAO) and the World 
Health Organisation (WHO). In 2000 the membership of the Codex Alimentarius 
Commission comprised 165 countries representing 98 % of the world’s population. 
In 2003, the Codex Alimentarius contained more than 230 standards, more than 
3,000 upper levels of pesticide residues and more than 1,000 assessments of food 
additives (Codex Alimentarius 2003). The Codex develops standards or gives rec-
ommendations to labelling issues, food additives, dietary food products, harmful 
substances in food, analytical methods, aspects of general food hygiene, the control 
of food imports and exports as well as levels of residues of veterinary pharmaceuti-
cals and pesticides on foods. The increasing relevance of this type of standards is 
underlined by the fact that an increasing number of countries are transforming the 
Codex’s standards into national law. 
 
The EU legislation on foodstuffs (with some exceptions like novel foods and novel 
food ingredients) leaves food industry companies free to market their products 
without pre-market approval. Food manufacturers have to assure that their products 
are safe and do not mislead the consumer. These requirements must be met under 
the sole responsibility of the company and are subject to post-marketing controls by 
public authorities. In April 1997 the European Commission published a Green Pa-
per “The general principles of Food Law in the European Union” which defines a 
regulatory framework which covers the entire food chain. The Green Paper had the 
objectives to ensure a high level of protection of public health and safety and of 
consumer protection, to ensure the free movement of goods within the single mar-
ket, to base legislation on scientific evidence and risk assessment, to ensure the 
competitiveness of the European industry and enhance export prospects, to place the 
primary responsibility for safe food with industry, producers and suppliers as well 
as to ensure that legislation is consistent, rational and clear (European Commission 
1997).  
 
Following a series of food scandals in the 1990s the European Commission sug-
gested in a White Paper on Food Safety in January 2000 the establishment of an 
independent European Food Safety Authority (EFSA) which should be responsible 
for independent scientific advice on all aspect related to food safety, operation of 
rapid alert systems and communication of risks (European Commission 2000). In 
addition, suggestions for a new legal framework concerning food safety, control 
activities, consumer information and international arrangements related to food 
safety were given in the White Paper. Furthermore, the European Commission an-
nounced its intention to streamline and simplify the EU decision-making process for 
foodstuffs “in order to ensure efficacy, transparency and rapidity” (European Com-
mission 2000).  
 5 
 
In the United States of America (USA) foods are regulated under the Federal Food, 
Drug and Cosmetics Act (FFDCA). This Act was the first and most comprehensive 
law in the world covering production, distribution and trade of foods, drugs, medi-
cal devices and cosmetics. The FFDCA defines foods and standards for food, adul-
teration of food as well as regulations for misbranding. Under FFDCA the Food and 
Drug Administration (FDA) oversees safety and labelling of food products with the 
exception of those containing meat or poultry which are controlled by the United 
States Department of Agriculture, Food Safety and Inspection Service (FSIS).  
 
In the USA there are no federal requirements that food manufacturing companies 
have to be registered or get pre-market approval of food as it is the case for manu-
facturers of pharmaceuticals and medical devices. However, for some categories of 
food, such as seafood and low-acid canned foods, complex quality control pro-
grammes for manufacturing are mandatory (Greenberg 2000). The US food safety 
system is based on strong but flexible science-based legislation and industry’s 
leader responsibility to produce safe foods. The regulatory approach used in the 
USA to control food safety refers to a so-called Hazard Analysis and Critical Con-
trol Points (HACCP) system. A HACCP system requires manufacturers to identify 
the likely hazards, like e. g. contamination from outside sources, or deterioration 
due to failure to maintain refrigeration. These “critical control points” are spots in 
the process where a failure could lead to a hazard (e. g. unsafe levels of dangerous 
micro-organisms). Manufacturers establish critical limits, then, if a manufactured 
product falls outside the limits, the maker knows something needs correction. 
HACCP systems require extensive record keeping, so the history of manufacturing 
processes can be easily reviewed and monitored (Greenberg 2000). 
 
The US food safety programmes are risk based in order to ensure that consumers 
are protected from health risks of unsafe food. Decisions within these programmes 
are mainly science based and involve risk analysis processes. Regulations in the 
food safety area are often developed and revised in a public process that encourages 
participation by the regulated industry, consumers’ organisations and other stake-
holders throughout the development and promogation of a regulation.  
 
Another important aspect of food regulation in the US are labelling requirements of 
foods. The two most relevant legislations in this area are the Fair Packaging and 
Labelling Act (FPLA) and the Nutrition Labelling and Education Act of 1990 
(NLEA) which is an amendment to FFDCA. Before the enforcement of NLEA FDA 
run a voluntary nutrition labelling programme which was existing more than 
20 years (Storlie et al. 2000). In 1990 the US Congress passed the NLEA which 
made nutrition labelling mandatory on most packaged food products and mandated 
that FDA initiate uniformity in the content and format of the nutrition label on the 
package. In addition, NLEA set up the regulatory framework for the approval of 
health claims which are of specific relevance for the development and marketing of 
Functional Food  
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Character of innovations in the food industry 
 
Traditionally the food industry is regarded as a sector with low R&D intensity 
(Martinez & Briz 2000, Grunert et al. 1997, Christensen et al. 1996). Due to lack of 
statistical information concerning the personnel or financial resources devoted to 
R&D activities of the EU food industry the situation of the food industry in Ger-
many is analysed as an example. In Germany, R&D personnel of the food industry 
reached around 2,300 in 1999 (BMBF 2002, 2000), representing around 0.4 % of all 
employees of the German food industry, compared to around 2.4 % in all industries 
in Germany (BMBF 2002). In 1999 the food industry in Germany spent around 210 
million € for R&D activities (BMBF 2000) and was responsible for 0.6 % of all 
funds devoted to R&D activities of the German industry compared to 9.7 % regard-
ing turnover and 8.6 % regarding employees (BMBF, 2000). Consequently in 1999 
the R&D intensity of the food industry reached 0.4 % compared to 3.5 % in all in-
dustries in Germany (BMBF 2002). This low R&D intensity is supported by the EU 
CIS survey of 1996 in which the food and beverages industry had the lowest R&D 
intensity of all industrial branches of the manufacturing industry (Eurostat & DG 
Enterprise 2000). 
 
Innovation activities in the food industry can be analysed on different levels and 
with differing methodological approaches. However, due to the missing bottleneck 
for food products there are high variations in the published figures concerning the 
number of new products in the European food industry. According to the CIS sur-
vey around 50 % of the EU food manufacturers in 1996 can be regarded as "innova-
tors" (Eurostat & DG Enterprise 2000). The big differences concerning the pub-
lished numbers of “new” food products can be illustrated for the example of Ger-
many. While investigations which are based on the EAN code of the products1, 
counted almost 21,000 new food products in 2001 (Madakom 2001), other studies 
which try to consider products with a higher degree of novelty found much lower 
figures. According to these investigations the number of newly launched food arti-
cles decreased from around 1,600 at the beginning of the 1990s to around 
1,050  products at the end of the decade (Deutscher Fachverlag 2001, Hermann 
1997, Hermann et al. 1996). 
 
The market research institute Datamonitor continuously collects information about 
product innovations of the food industry in more than 50 countries. An overview 
about the product innovations in Germany collected by this institute between mid 
1999 and mid 2001 is given in table 1. During this period 1,579 new food products 
were introduced in the German market. The highest number of product innovations 
was observed in dairy, confectionery and non-alcoholic beverages (table 1), under-
lining the findings of the other studies. Around 56 % of the product innovations of 
1999 to 2001 have been launched by large companies with more than 
                                                      
1  In such surveys each product with a new EAN-code are considered as an “innovation”, i. e. each 
modification e. g. in the packaging or other minor changes in the product design leading to a new 
EAN-code and thus to a new product.  7 
 
500 employees (table 1). Regarding the different food categories, large companies 
showed a high relevance in innovations in baby food, sauces, frozen food and dairy 
products, whereas SMEs had a specific relevance in innovations in all types of bev-
erages (table 1). 
 
Table 1:  Product innovations in Germany 1999 to 2001 
Food  
category 
New products  Large company  SME 
Number in  % Number  Proportion Number  Proportion
Baby food  44  2.8  44  100.0 %  -  - 
Dairy  250 15,8  156  62.4  %  94 37.6  % 
Bakery  197 12.5  113  57.4  %  84 42.6  % 
Pasta and rice  19  1,2  10  52.6 %  9  47.4 % 
Confectionery  250 15,8  135  54.0  % 115 46.0  % 
Canned food  50  3,2  27  54.0 %  23  46.0 % 
Chilled food  69  4,4  41  59.4 %  28  40.6 % 
Frozen food  157  9,9  115  73.3 %  42  26.7 % 
Sauces  52  3,3  39  75.0 %  13  25.0 % 
Snacks  42  2,7  22  52.4 %  20  47.6 % 
Hot beverages  67  4,2  25  37.3 %  42  62.7 % 
Non-alcoholic 
beverages 
228 14,4  104  45.6  % 124 54.4  % 
Beer  97  6,1  32  33.0 %  65  67.0 % 
Alcoholic  
beverages 
57  3,6  23  40.4 %  34  59.6 % 
Total  1,579  100.0  886  56.1 %  693  43.9 % 
Source:  Own investigations based on Datamonitor 2001 
 
The same discrepancy in number of new food products which was illustrated for the 
German market can be found in the USA as well. The specialised magazine New 
product news (Dornblaser 1998) reported that the number of new food products 
introduced in 1995 and 1998 in the USA ranged from 13,000 to 16,000 food prod-
ucts. On the other hand, Marketing Intelligence Service Ltd. found that of around 
11,000 new food products introduced in the US market in 1996 only 7.2 % featured 
innovations in formulating, positioning, technology, packaging or creating a new 
market (Messenger 1997). According to a more stringent classification of new 
products Ernst & Young found that instead of the more than 15,000 new food prod-
ucts, which are reported annually by New Product News, only 1,100 to 1,200 new 
products are introduced each year in the US food market, of which 22 % are new 
brands and 78 % are line extensions (Lord 2000).  
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Given the high number of product innovations in the food industry it is not surpris-
ing that a relatively high percentage of the newly introduced products only “sur-
vive” a limited period of time in the market. During 2000 and 2001 around 50 % to 
67 % of the new products have been withdrawn within one year from the food re-
tailing shelves in Germany, indicating the high competition in this field. After three 
years the “survival” rate of the new products tends towards the 25 % level (Mada-
kom 2001). This high rate of product failure in food retailing is supported by other 
authors as well (Mehler 1997, Martinez  & Briz 2000, Behr's Verlag 2002) and 
mainly caused by limited sales and shelve areas in food retailing and in tendency 
saturated food markets with low total growth rates in the EU.  
 
High failure rates of launched food products can be found on the US market as well. 
The 1996 IRI Pacesetters report included estimates of the rate of new product suc-
cess and failure and calculated that approximately 72 % of new products and 55 % 
of line extension fail. Another study which analysed the introduction of new prod-
ucts of 20 major US food companies in 1995 found that of the 1,935 new products 
introduced by these companies 174 were “new” and 1,761 were line extensions. 
These new items experienced a success rate of 52 % while line extensions had a 
78 % success rate what equals to an overall success rate of 76 % (Lord 2000).  
 
Given the high numbers of product and process innovations, several studies have 
shown that radical innovations are very rare in the food industry. Most innovations 
in the food industry can be characterised as incremental innovations or even imita-
tions (Grunert et al. 1997). According to different studies, only around 3 % of the 
new products which were introduced in 1996 and 1997 in the German food market 
were assessed as “innovative”, while 80  % were regarded as me-too products 
(Behr’s Verlag 2002, Mehler 1997), and were also reported for the US and the 
Spanish food industry (Martinez & Briz 2000). Galizzi & Venturini (1996) attribute 
the incremental nature of food product innovation to constraints on the demand 
side. European consumers tend to be conservative in their food choices and may 
initially reject new products. Therefore, fundamentally radical innovations are a 
high risk for food manufacturing companies. 
 
Impact of regulation on innovation activities in the food industry 
 
In following part of the paper three very innovative fields in the food industry are 
analysed whether the existing regulatory framework has hindering or facilitating 
impacts on the development and introduction of new products: the use of genetic 
engineering approaches for food production and food processing, the field of health-
oriented Functional Foods and organic food products.  
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Genetically modified organisms (GMOs) and Novel Foods 
 
Since the mid 1990s genetically modified (GM) plants are marketed and cultivated 
which directly or via animal feed can enter the food chain. In addition, genetic en-
gineering approaches are regarded by their protagonists as major tools to increase 
productivity and efficiency in food processing in future (Garza & Stover 2003), On 
the other hand, an intensive public debate is carried out globally concerning the 
safety of these approaches and derived novel foods as well as their socio-economic 
impacts (Otsuka 2003). Critics of genetic engineering see the potential that this 
technology may result in harm for the environment and human or animal health. In 
addition, the wider impacts of the use of genetic engineering in the agro-food sector 
on society as a whole are often questioned in the public debate (Menrad et al. 2003).  
 
Since GMOs and derived novel food products represent new developments in the 
area of food production and food processing, there have been relatively restricted 
experiences with this type of products. Therefore, state authorities took specific 
activities to deal with potential risks of GMOs. The general targets of the respective 
legislations are to ensure human health when consuming GMOs or derived novel 
foods, to prevent or minimise potential harm of GMOs to the environment as well 
as to provide the necessary information in order to ensure the freedom of choice of 
consumers or users of such products. In particular, the EU policy related to GMOs 
was intensively influenced by the emergence of the BSE and other food crises dur-
ing the 1990s, the public criticism and undermined trust in public authorities to ade-
quately manage such crises in the sensitive area of food production and food proc-
essing as well as the low consumer acceptance of agro-food biotechnology 
(Loureiro 2003, Eurobarometer 2001, Gaskell et al. 2000). 
 
The fundamental question which arises concerning regulation of GMOs is whether 
GM crops or other GMOs have to be acknowledged like conventional crops or or-
ganisms, and therefore it is sufficient to use the general legislation valid for such 
crops or organisms or whether it is necessary to adopt different and specific regula-
tions for GMOs. In the USA GM crops are considered specific and different in 
terms of intellectual property rights since a patent can be granted to them but not to 
conventional crops. On the other hand, the introduction of GM crops in the envi-
ronment and into the market follows the principle of “substantial equivalence” and 
therefore the same steps are required like for conventional crops (Esposti & Sorren-
tino 2002).  
 
The EU takes the opposite approach concerning regulation of GMOs compared to 
the USA. Even after Directive 98/44//EC patents cannot be granted to GM crops, 
but they are protected by the same breeders rights acknowledged to conventional 
crops. In contrast to the US procedure, the EU approach for environmental release 
and market approval of GMOs follows a rather strict interpretation of the “precau-
tionary principle”. For this purpose specific regulations have been put into force 
dealing with GMOs which require different and often more complex procedures 
than for conventional products (Esposti & Sorrentino 2002).  10 
 
 
GMOs have been regulated by the EU since the beginning of the 1990s. The EU 
Directives 90/219/EEC and 90/220/EEC were the first regulations which tried to 
establish a system for controlling R&D and commercialisation of GMOs in the EU. 
These regulations were designed to protect citizens’ health and the environment, 
and addressed authorisation, labelling and traceability issues relevant for GMOs. 
Since its enpassment in the year 1990 Directive 90/220/EEC was criticised by dif-
ferent stakeholder groups. In addition, all notifications for market approval of agri-
cultural GMOs raised concerns of one or several EU Member States during the 
1990s (Sauter & Meyer 2000). Therefore, in June 1999 a de facto moratorium on 
commercialisation of GMOs was agreed by the Community's Council of Environ-
mental Ministers to suspend all approval applications for GMOs until implementa-
tion of the revised Directive 90/220/EEC, in order to provide a more strict legal 
framework covering not only safety issues but also labelling and traceability of 
GMOs (Lheureux et al. 2003). 
 
Directive 2001/18/EC on the Deliberate release into the environment of genetically 
modified organisms was passed in February 2001 which replaced Directive 
90/220/EEC. This Directive modified the rules for environmental release and mar-
ket approval of GMOs significantly by restricting market approval to ten years and 
the requirement of post-market monitoring of each GMO. In further regulations a 
tolerance level of 0.9 % is foreseen for adventitious admixture of GM material: food 
products which exceed this level have to be labelled accordingly. In addition, the 
European Commission has suggested labelling rules for GM derived novel foods 
irrespectively whether DNA or protein of GM origin can be found in the final prod-
uct. Another area of intensive debate is to ensure co-existence between GM crops, 
conventional and organic farming as well as the question of liability in case eco-
nomic damage results from admixture of gene flow (European Commission 2003).  
 
In contrast to the EU, in 1992 the US Food and Drug Administration (FDA) out-
lined a policy that did not require the market approval for GM crops and placed the 
responsibility for investigating and reporting potential problems associated with 
GM foods to the companies. During this phase FDA recommended voluntary label-
ling of specific GM foods but opposed mandatory labelling of GM foods (FDA 
1992). The practise of FDA was modified in 2001 when the Authority announced a 
mandatory notification by manufacturers for plant-derived bioengineered foods 
(FDA 2001). In 2003 the USA with Canada and Argentina decided to instigate an 
action at the World Trade Organisation (WTO) against the EU, due to the inability 
to sell GM crops and derived products in the EU and because of concerns about the 
impact of the EU de facto moratorium on GMOs on imports of such products by 
developing countries (Kinderlerer 2003).  
 
In the EU there is still a broad pipeline of R&D activities related to agricultural and 
food GMOs which is fuelled by differing organisations like large multinational 
companies, SMEs, universities and non-university research institutions (Lheureux et 
al. 2003). However, EU publication intensity in plant biotechnology grew signifi-11 
 
cantly below average compared to other field of biotechnology (Reiss & 
Dominguez Lacasa 2003). In addition, field trials with GMOs have dropped by 
76 % since the introduction of the de facto moratorium (Lheureux et al. 2003) and a 
significant number of companies mentioned in a survey carried out in 2002 that 
they have cancelled R&D projects related to GMOs in the last four years (table 2). 
Companies highlighted the unclear legal situation in the EU, high costs and time 
requirements for safety testing, low consumer and user acceptance of GM products 
as well as uncertain future market perspectives as main obstacles for GMO-related 
innovation activities in the EU (Lheureux et al. 2003). Although 14 GM plants have 
got market approval for the EU before 1998 (and 20 are awaiting market approval), 
only 20,000 to 25,000 hectares of Bt maize are commercially planted in Spain 
(Brookes 2003). Altogether, the impression arises that the de facto moratorium has 
had a negative impact on pre-market innovation activities related to GMOs in the 
EU (Menrad 2003b). This relates in particular to SMEs which often have given up 
such projects due to their limited financial and personnel resources. 
 




GMO projects cancelled 
Yes No 
SME  33  54.5 %  45.5 % 
Large company  28  67.5 %  32.5 % 
University institutes  44  25.0 %  75.0 % 
Public research institutes  37
1)  21.6 %  75.1 % 
Total 165
2)  38.8 %  60.6 % 
1)  One respondent answered “Don't know” 
2)  Other institutions are included, 3 questionnaires without an answer to this question. 
Source:  Lheureux et al. 2003 
 
In contrast to the situation in the EU, field trials with GMOs did not fall signifi-
cantly in the USA in the last six years. In addition, a high number of mainly herbi-
cide and/or insect resistant GM plants have been approved for commercial use in 
USA and Canada (AGBIOS 2004). With almost 43 million hectares in 2003 USA 
also has the world-wide leadership concerning commercial cultivation of GM plants 
(mainly soybeans, maize and cotton) (James 2003), while in Canada particularly 
GM rapeseed is grown for commercial use.  
 
The EU regulatory framework adopted during the 1990s has played an important, 
largely negative role for the development of GMOs in the EU in the last decade. 
During this time period increased regulatory oversight in agro-food biotechnology 
coincided with growing negative public opinion and diminished trust in public au-
thorities and regulatory agencies. In this context companies regarded the “con-
stantly changing regulatory environment” as one major constraint for R&D and 
commercialisation of GMOs in the EU. In particular the practical handling of the 
existing regulations was strongly criticised as being to slow, bureaucratic and caus-12 
 
ing extraordinary costs. Politics was criticised for not taking any clear decision re-
gards GMOs (which will form a reliable planning basis for the companies) and pe-
riodically intervening in the regulatory processes.  
 
Combining the findings of Lheureux et al. (2003) with the analysis of the perform-
ance of scientific publications in different subfields of biotechnology (Reiss & 
Dominguez Lacasa 2003) provides evidence, that the unclear legal situation with 
respect to the commercialisation of GMOs which emerged in the second half of the 
1990s led to the cutting down of research activities in plant biotechnology which 
can be measured as decreasing scientific output. In more general terms, the unclear 
legal situation related to GMO on the commercial side seems to have a negative 
feedback on the science base. This could give reason for concern that once the legal 
environment would become more stable and/or more favourable for commercialisa-
tion of GMOs, the EU knowledge base would be less prepared to provide the re-
quired know-how.  
 
The “proof of principle” of the differing GMO-related regulatory approaches of 
USA and EU cannot be provided so far since no consumer or user reactions which 
are based on purchasing behaviour can be measured in the EU. In this sense the case 
study on GMOs represents a field in which political decisions impede the function-
ing of the market mechanism, i. e. other areas of political intervention are regarded 
as being more relevant than innovation aspects. In addition, the GMO case repre-
sents a good example of the differing acceptance levels of risk and the handling of 
uncertainty which a society is willing to accept – what results in differing regulatory 




In addition to satisfy hunger and provide humans with the necessary nutrients, 
Functional Food is intended to provide additional benefits to consumers by prevent-
ing nutrition-related diseases and increasing physical and mental well-being of hu-
mans. For this purpose Functional Food contains specific “functional” ingredients 
to which particular effects on human health or well-being are attributed. These sub-
stances aim at reducing the risk of e. g. coronary heart disease, specific types of 
cancer, diabetes or osteoporosis which are amongst the most important causes for 
death in many industrialised countries (Menrad et al. 2000).  
 
From a legal point of view, Functional Food is positioned in a transitional zone be-
tween food and pharmaceuticals. In the EU, its Member States and USA food and 
pharmaceutical products are subject to different regulation regimes and are – at least 
in the EU – regulated by differing relevant authorities. Another fundamental differ-
ence between these two product fields is the aspect that pharmaceuticals and other 
medicinal products require pre-market approval by state authorities, while EU and 
US legislation on foodstuffs (with a few exceptions like e. g. novel foods or food 
additives) leaves companies free to market their products, if they are safe and do not 13 
 
mislead consumer and afterwards they are subject to post-marketing control by pub-
lic authorities. Since Functional Food is positioned in a “grey zone” between these 
two areas, high uncertainty emerges both for commercial activities of companies as 
well as for consumers. Due to the novelty character of Functional Food, additional 
questions arise concerning the safety and efficacy of such products, the required 
testing and monitoring methods, their impact on consumers’ nutritional behaviour 
as well as the institutional procedures and responsible authorities.  
 
In the EU there exists no harmonised or specific regulatory framework nor a precise 
legal definition of Functional Food, i. e. the general regulations valid for food are 
relevant for Functional Food as well. However, there are differences in the practical 
handling of these general regulations with regard to Functional Food between the 
EU Member States (Groeneveld 2000) – what hinders the development of a com-
mon market for such products. Due to the absence of specific regulations, the so-
called Novel Food Regulation (Regulation 258/97/EC) was used for single Func-
tional Food products for applying for market approval in the EU in recent years. 
Another important bottleneck for Functional Food represents the fact, that there 
exists no harmonised legislation on health claims on Community level so far, what 
results in differences in the practical handling of such claims between the Member 
States (Menrad 2003a). Under the existing regulatory framework in the EU it is 
prohibited to attribute to any foodstuff the property for preventing, treating or cur-
ing a human disease or referring to such properties. The regulation on Nutrition and 
health claims proposed by the European Commission in July 2003 includes far-
reaching suggestions concerning the use and registration requirements of generic 
claims as well as for the requirements to approve specific health-related claims. In 
addition, it is foreseen to prohibit certain claims related to e. g. general well-being 
or slimming (European Commission 2003b).  
 
In contrast to the EU situation, food manufacturers in USA can use about 13 generic 
claims to inform consumers about the health benefits of Functional Food products 
which have been approved by the Food and Drug Administration (FDA) since 1990 
(Ringel Heller & Silverglade 2001). The regulatory framework for these activities 
was provided with the passing of the Nutritional Labeling and Education Act 
(NLEA) in 1990, which established mandatory nutritional labelling for food prod-
ucts in the USA but also set up the regulatory framework for the approval of health 
claims. In order to protect consumers from unproven health claims, the respective 
claims have to be supported by the totality of publically available scientific evi-
dence and there must be “significant scientific agreement” among qualified experts. 
In addition to labelled food products, Functional Food is often marketed as a food 
supplement in the USA (Heasmen & Mellentin 2001). 
 
Despite definition problems and highly varying market figures for Functional Food 
it can be concluded that the market of Functional Food (and interrelated food sup-
plements) has developed faster and to larger market values in the USA compared to 
the EU. While the total US market of Functional Food is estimated to 15 to 
20 billion US$ (figure 1), what equals to around 2 % of the US food market (Marra 14 
 
2003, CMA 2002). The corresponding EU sales figures amount to around 4 to 
8 billion €, what equals to a Functional Food market share of below 1 % of the total 
EU food and drinks market. Within the EU, Germany, France, the United Kingdom 
and the Netherlands represent the most important markets for Functional Food, 
while Mediterranean consumers showed limited interest in this type of food in re-
cent years. Important product categories of Functional Food in the EU are func-
tional dairy products, ACE drinks and non-alcoholic beverages fortified with other 
functional ingredients, cholesterol-lowering margarine and a multiplicity of niche 
products mainly in confectioneries, bakery products, breakfast cereals or babyfood 
(Menrad 2003a, Hilliam 2000).  
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Source:  Nutrition Business Journal 2001 cited in CMA 2002 
 
According to the available future market estimations, it can be assumed that Func-
tional Food will increase its market volume in the coming years considerably. Most 
market estimations assume that 3 % to 5 % of the food market represent the growth 
limit for Functional Food in Europe in the coming ten years (Menrad 2003a, Dust-
mann & Weindlmaier 2002). In this sense, Functional Food has a significant growth 
potential but will not develop to a mass market in future, i. e. it represents a multi-
niche market with a high number of limited product segments and very few high-
value product categories. The most important drivers of innovations in the field of 
Functional Food are scientific and technical developments in nutrition-related re-
search, the interest of food companies to participate in growing segments of an al-
most stagnant food market as well as consumers’ interest in innovative products 
supporting their health and well-being. So far, multinational food companies as well 15 
 
as internationally acting food ingredient suppliers are best positioned to overcome 
specific challenges during the R&D and marketing process of Functional Food, 
while small and medium-sized food industry companies do only have limited op-
portunities in this field (Menrad 2003a) 
 
A major bottleneck for the future development of Functional Food in the EU repre-
sents the unclear legal situation concerning procedure and factual requirements for 
market approval of such products as well as the use of health claims. This lack of a 
clear regulation and definition of Functional Food and non-harmonised procedures 
between the EU Member States impedes the potential growth of this market. Thus, 
the EU food industry cannot take full advantage of a potential growth segment in 
the mature and stagnating food market in the EU. In this sense, an important basic 
activity with a mid-term perspective is the clarification and standardisation of the 
regulatory status of Functional Food in the EU both for consumers and industrial 
companies as legal basis for economic activities (Menrad 2001).  
 
Organic agriculture and food production 
 
At the end of the 1980s both the EU and USA took initiatives to develop a specific 
regulatory framework for production, processing and trade of organic products. Ma-
jor targets of the related policies were reducing costs of market stabilisation meas-
ures for conventionally produced agricultural commodities, supporting environmen-
tally friendly ways of agricultural production and protecting consumers from being 
mislead in the area of organic foods (Lampkin et al. 1999). While the US policy 
focussed almost solely on defining standards for producing, processing, marketing 
and importing organic products (Greene & Kremen 2003), the European Commis-
sion followed a dual strategy which firstly supported conversion of conventional 
farms to organic agriculture by direct payment schemes and advisory assistance, 
and secondly improved market transparency by defining, implementing and control-
ling clear standards for production, processing and marketing of organic products 
(Lampkin et al. 1999). 
 
Regarding timing of the respective legislation the USA took the leadership when 
passing the Organic Food Production Act (OFPA) in 1990 by the US Congress. 
However, it took more than ten years until with the National Organic Programme, 
which was published in December 2000, OFPA was fully implemented and nation-
wide standards for organic products were put into force in the USA (Greene & 
Kremen 2003). With Regulation 2078/92/EC a common regulatory framework was 
established for EU Member States to implement policies to support organic farming 
which was introduced in most countries in 1994 and 1995. An important part of this 
Regulation are direct payments for conversion to organic farming for which maxi-
mum rates eligible for co-financing by the EU are defined in the Regulation. An-
other important key element of EU legislation in the field of organic food products 
represents Regulation 2092/91/EEC which created a common legal definition for 
organic farming and the respective products, covering all EU Member States and 
trade with third countries. This Regulation required that all fresh and processed 16 
 
products of plant origin must meet the organic standards defined in the Regulation 
and that producers and operators must submit their business activities to a publi-
cally-controlled inspection system. In 1999 analogous requirements were put into 
force for production and marketing of organic livestock products (Lampkin et al. 
1999).  
 
Both in the USA and in the EU the introduction of the organic food regulation has 
had a strong impetus for supply and demand of such products. However, EU farm-
ers and food processors reacted faster and in much higher numbers in order to bene-
fit from the market opportunities provided by organic foods. This can be illustrated 
by the fact that until 2000 around 2.1 % of all farms (figure 2) which operated 
3.1  % of the total Utilised Agricultural Area of the EU (Organic Centre Wales 
2003b) have converted to organic agriculture in comparison to 0.32 % of all US 
farms being organic in 2001 with 0.25 % of the operated farm area (USDA 2003, 
Yussefi & Willer 2003). In particular producers of plant products like fruits and 
vegetables, potatoes or cereals have increased organic production significantly dur-
ing the 1990s, but at least in the EU production of organic livestock products like 
milk or eggs seems to grow at high rates in recent years (Hamm et al. 2002).  
 















































































Sources: Organic Centre Wales 2003a, Yussefi & Willer 2003 
 
Besides higher price premia for organic products, this much stronger increase of 
domestic organic production in the EU can be linked to the direct payments pro-
vided by the European Commission and national governments in order to support 17 
 
conversion to organic agriculture. Since conversion of conventional farms to or-
ganic agriculture reduces natural yields significantly and often induces increasing 
production costs (at least in the first years after conversion), this step includes high 
technical, market-related and financial risks for farmers. In order to reduce uncer-
tainty and risks associated with such a conversion process, it does not seems to be 
sufficient to solely reduce transaction costs on the market by introducing standards 
for organic products and inspection systems for controlling these standards (like it 
was the case in the USA), but additional financial incentives seem to be necessary 
to foster such a development – as it was implemented in the EU. It can be ques-
tioned how long such direct payments should be given to farmers willing to convert 
to organic agriculture.  
 
Table 3:  Organic products in % of the total sales value of selected products 
in EU Member States in 2000 





  Eggs 
Austria    10.2  4.8 6.1 3.8 7.7 3.5 2.7 
Belgium  1.5 2.7 1.1 0.8 1.6 0.8 0.6 
Denmark  14.5 8.3 12.8 3.2 13.1 3.0 11.9 
Finland  5.5 2.3 7.1 1.6 0.6 1.0 2.3 
France  1.7  1.9 -  - 0.9  0.4  2.2 
Germany  4.7 3.5 3.6 1.8 1.3 3.1 1.9 
Greece  0.2 0.0 0.3  -  -  -  0.0 
Ireland  - - - - - - - 
Italy 5.3 
-  0.3
  2.0 0.5 0.1 0.6 
Luxembourg  3.0 1.3 0.4 0.3  -  0.6  - 
Portugal   - 
-  0.9
  1.2 -  -  - 
Spain  - - - - - - - 
Sweden  9.7 4.8 4.3 0.9 1.8 1.0 2.1 
The  Netherlands  1.2 6.0 3.4 0.5 1.6 0.8 2.5 
United  Kingdom  1.6 0.7 4.4 1.9 1.1 0.4 2.5 
Source:  Hamm et al. 2002 
 
On the consumer markets, there is a fastly growing demand for organic products in 
the USA and EU. Although there are some difficulties concerning data availability, 
both markets are estimated to around 10 to 13 billion € with significant regional 
differences (Marra 2003, Yussefi & Willer 2003). In the EU “mature” organic mar-
kets in countries like Austria, Denmark, Sweden, Finland (with high per capita sales 
of organic products) can be observed parallel to “emerging” organic markets (e. g. 
in Greece, Portugal) (table 3). In most EU countries organic plant products achieve 
higher market shares compared to organic livestock products. For future growth of 
the organic market which is expected both in the USA and EU clear and reliable 18 
 
standards for organic products and corresponding consumer information, increasing 
interest and activities of the processing industry as well as increasing sales in con-
ventional supermarkets are regarded as key success factors. In this sense, the US 
and EU regulation provided the starting point for innovation activities in the organic 
food area which was rewarded by consumers in recent years. 
 
Empirical results of a survey of EU food processing companies 
 
In the following part of the paper empirical results among a survey of EU food 
manufacturing firms are presented which assess the current framework in the EU 
and its impact on innovation activities. In this context we differentiate only between 
the food and the other sectors, in order to characterise the specifics of the food sec-
tor. In total, we received completed questionnaires from more than 260 companies, 
thereof 20 food companies. The companies were randomly selected by using the 
commercial database of Dun & Bradstreet. At first, the companies were approached 
via fax or via mail and asked to fill out the questionnaire either online or to 
download a pdf-file and return the questionnaire via mail or fax. Secondly, two 
thousand companies active in the six sector above in further Member States and one 
thousand companies in the USA and Canada were sent a paper version of the ques-
tionnaire. 
 
The response rate was rather low compared to other non-mandatory business sur-
veys in Europe, because the complex issue of regulation and innovation within 
companies is not yet broadly acknowledged and taken into account, consequently 
there is very often no one explicitly responsible for this issue. In more than one 
third of the answers, the chief executive officer answered the questionnaire. The 
other answers stem from members of the R&D or from the members of the market-
ing department. Members of the legal department are almost not included in an-
swering the questionnaire. 
 
In Figure 3, we present a differentiation of the importance of regulations as hamper-
ing factors for innovation. Although governmental regulations are more severe ob-
stacles for innovation than non-governmental regulations, we find in the food sector 
the highest values and the largest discrepancies to non-governmental regulations. 
Furthermore, in general the implementation of governmental regulations is a 
slightly more severe problem than the regulations themselves. Since there are rather 
different types of regulations, we have to differentiate more precisely between dif-
ferent types of regulations relevant for the development and introduction of new 
products and services. Figure 4 confirms that especially labelling and environmental 













Governmental regulations (i.e. directives, laws) Implementation of governmental regulations
Non-governmental regulations Implementation of non-governmental regulations  
Source: Company survey of Fraunhofer ISI 2003 
 
Figure 4:  Importance of selected regulations relevant for new products 
and services differentiated by sector (1 = very low importance to 








Price regulations Constraints for the supply of specific products and services
Environmental regulations Regulations of licenses and permits
Labelling, consumer information Intellectual Property Rights  
Source: Company survey of Fraunhofer ISI 2003 20 
 
 
Regulation may be a hampering factor for the development and market introduction 
of new products and services. However, regulation may also have a positive influ-
ence on these activities, by forcing firms to search for new products and services. 
Furthermore, regulation may create new opportunities for new products and ser-
vices by providing an adequate framework. Based on this background, we asked the 
companies to assess whether those regulations in the direct context of introducing 
new products and services into the market, which have been assessed as important 
are more likely to have positive or negative impacts on these aspects. 
 
In general, figure 5 confirms that the regulations relevant for the introduction of 
new products in the food sector have more negative and less positive impacts than 
for the rest of the sample. They have both not the positive impacts on legal security 
including liability claims, and they have more detrimental impacts on domestic and 
foreign market shares and on the costs and risks to introduce new products into the 
market. These results raise serious concerns regarding the regulatory framework for 
the food sector in the EU relevant for the introduction of new products.  
Figure 5:  Impacts of the regulatory framework relevant for the intro-
duction of new products and services (-1 = negative impact to 
+1 = positive impact) 
-1 -0.8 -0.6 -0.4 -0.2 0 0.2 0.4 0.6 0.8
Turnovers and profits with new products and services
Costs for the development and market introduction of new products and services
Risks for the development and market introduction of new products and services
Material and energy costs
Labour costs
R&D or technological flexibility
Organisational flexibility
Flexibility in the production or service-providing process
Time to market for new products and services
Product and service assortment
Product and service quality
Domestic market share
Foreign market share
Development of markets for new products and services
Health or safety of consumers
Health or safety of the work force
Consumer and user acceptance
Environmental quality
Legal security




Source: Company survey of Fraunhofer ISI 2003 
 
Role of regulations for R&D and marketing of new products in the food industry 
 
The focus of innovation activities in the food industry has shifted in recent years. 
While in the past innovation activities of the food industry strongly depended on 21 
 
technical developments in their supplying industries, currently innovation activities 
of the food industry are mainly demand-oriented what results in a high number of 
new or modified products which are often combined with process innovations. This 
shifting orientation of innovation activities can be observed in all three case studies 
in which demand-relating factors are important drivers for the R&D, market intro-
duction and penetration of new products.  
 
In the coming years the agro-food sector is confronted with multiple new scientific 
approaches and technical opportunities which often have an interdisciplinary char-
acter. However, in particular SMEs of the food industry are not well prepared to 
profit from these developments. Therefore, the creation and building-up of interfac-
ing competencies as well as the establishment of new external knowledge and com-
petence networks seems to be of strategic relevance for many companies of the EU 
food industry. In this context it is advisable to widen the knowledge base of external 
co-operations and include clients, retail companies, research institutes, specialised 
service companies as well as other companies of the food and supplying industries 
in such networks. 
 
As illustrated in the Functional Food case, in many innovative fields with relevance 
for the food industry the political and regulatory framework conditions in the EU 
often do not keep pace with scientific and technical discoveries or developments on 
the demand side. This relates in particular to regulatory aspects in which intensive 
discussions and co-ordination activities are required between the different Member 
States. Such a situation of legal uncertainty or non-harmonised regulatory condi-
tions between the different Member States often impedes innovation activities and 
may result in loss of market opportunities. In this sense, a clear and harmonised 
regulatory framework in innovative fields seems to be a necessary but not sufficient 
prerequisite for the development of new products or services. Such a situation of 
legal and regulatory certainty is in the interest of both industrial companies (as basis 
for commercial activities) and consumers (in particular for “credence goods”). In 
this sense there is need for clarification, harmonisation and implementation of regu-
lations in the EU in particular for those innovative fields with relevance for the food 
industry in which consumers are interested in the respective products.  
 
In particular in highly interdisciplinary-oriented innovation fields of the food indus-
try (like Functional Food) the institutional organisation and administrative respon-
sibilities impede innovation activities, since differing competent authorities with 
varying decision-making processes and procedures are responsible for the imple-
mentation, administration and control of existing regulations. In this sense, scien-
tific and technical innovations require organisational changes which often take 
place with significant time delays. This is valid both for the EU as well as for the 
Member States. Therefore, a more flexible framework for regulations should be 
created for newly emerging innovation fields which can be jointly formed by public 
authorities and early innovators.  
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As shown in the case study on organic food products, the definition of standards 
and the creation of labelling and control procedures does not seem to be sufficient 
for an early and fast take-off on the supply side. Although with these activities 
transaction costs are reduced on the market side, the high technical and market-
related risks impede farmers to convert conventional farms to organic agriculture. In 
such a case time-restricted and adopted final incentives seem to be an adequate in-
strument to speed up the adoption of an innovation. Such financial payments can be 
justified because positive environmental effects and reduced costs for financing 
conventional agricultural production are expected by increasing the rate of organic 
farming. 
 
The analyses in the case studies have identified the creation of interfacing compe-
tencies as one of the most relevant tasks for SMEs of the EU food industry in order 
to successfully carry out innovation activities in future. Therefore, national and in-
ternational policies should not solely concentrate on stimulating knowledge genera-
tion with relevance for the food industry, but should have the additional target to 
support advances of the knowledge base of the food industry companies themselves. 
In this sense, political activities should be stronger targeted to the diffusion of new 
scientific approaches and technologies in the food industry than exclusively on the 
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